BCL2 and pancreatic insulinoma: Western blot analysis indeed revealed a marked but not significant upregulation of Bcl-2 after incubation with Regorafenib in most insulinoma protein lysates compared to DMSO-treated control lysates ex vivo (Fig. 5a).